fda bans compounded tirzepatide Breaking News: Compounding Pharmacies Take the Fight to the Fifth Circuit The Outsourcing Facilities Association (OFA) has filed an appeal challenging the FDA's decision to restrict compounding pharmacies from producing tirzepatide, the Lilly seeks to intervene in

However, due to safety concerns and lack of clinical approval, its use for any medical purpose is not recommended at this time

Employer Strategies On-Demand Webinars SmithRx Key Takeaways GLP-1s are highly effective for diabetes and obesity but surged demand and costs, use up ~587% and list prices near $1,000/mo, forcing prior auths and spiking employer drug spend

The most effective approach often involves using a liposomal delivery system, which helps protect the nutrient through the digestive tract for better cellular uptake

I try to caution everybody that social media influencers often don't have medical degrees or training

We understand that weight loss is about more than food choices

Epinephrine has the shortest half-life of the catecholamines